News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
580,745 Results
Type
Article (24319)
Company Profile (82)
Press Release (556338)
Multimedia
Podcasts (120)
Webinars (14)
Section
Business (182594)
Career Advice (812)
Deals (28994)
Drug Delivery (168)
Drug Development (64877)
Employer Resources (85)
FDA (14754)
Job Trends (11449)
News (273476)
Policy (25842)
Tag
2027 BioCapital Standard (4)
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Digital (1)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (3)
2027 Genetown Elite (3)
2027 Genetown Premier (1)
2027 Genetown Standard (6)
2027 Pharm Country Digital (1)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (7)
40 Under 40 (2)
Academia (1480)
Accelerated approval (59)
ADA (43)
Adcomms (25)
Allergies (198)
Alliances (39650)
ALS (216)
Alzheimer's disease (1512)
Antibody-drug conjugate (ADC) (588)
Approvals (15524)
Artificial intelligence (747)
ASCO (285)
Autoimmune disease (404)
Automation (71)
Bankruptcy (242)
Belgium (28)
Best Places to Work (9377)
BIO (56)
Biologics (77)
BIOSECURE Act (15)
Biosimilars (277)
BioSpace Insights (85)
Biotechnology (52)
Bispecific (44)
Bladder cancer (216)
Brain cancer (67)
Breast cancer (714)
Cancer (6221)
Cardiovascular disease (493)
Career advice (712)
Career pathing (15)
CAR-T (344)
CDC (39)
CDMO (170)
Celiac Disease (4)
Cell-line development (1)
Cell therapy (976)
Cervical cancer (58)
Clinical research (59743)
Collaboration (2281)
Commercialization (49)
Company closure (4)
Compensation (1206)
Complete response letters (77)
COVID-19 (1861)
CRISPR (114)
CRO (3)
C-suite (1269)
Cystic fibrosis (145)
Data (9194)
Decentralized trials (2)
Denatured (19)
Depression (156)
Dermatology (170)
Diabetes (676)
Diagnostics (5696)
Digital health (58)
Diversity (4)
Diversity, equity & inclusion (10)
Drug discovery (347)
Drug pricing (167)
Drug shortages (31)
Duchenne muscular dystrophy (305)
Earnings (76967)
Editorial (50)
Employer branding (9)
Employer resources (71)
ESMO (398)
Events (98965)
Executive appointments (1095)
Eye disease (11)
FDA (19171)
Fibrodysplasia Ossificans Progressiva (15)
Fragile X (5)
Friedreich's ataxia (25)
Frontotemporal dementia (31)
Funding (1608)
Gene editing (232)
Generative AI (54)
Gene therapy (749)
GLP-1 (948)
Government (3602)
Grass and pollen (7)
Guidances (413)
Healthcare (13818)
Hematology (145)
HIV (96)
Huntington's disease (59)
Idiopathic pulmonary fibrosis (9)
IgA nephropathy (140)
Immunology and inflammation (263)
Immuno-oncology (121)
Indications (255)
Infectious disease (2187)
Inflammatory bowel disease (210)
Inflation Reduction Act (12)
Influenza (126)
Intellectual property (311)
Interviews (116)
IPO (13604)
IRA (41)
Job creations (2433)
Job search strategy (609)
JPM (62)
Kidney cancer (26)
Kidney disease (127)
Labor market (49)
Layoffs (373)
Leadership (19)
Legal (5399)
Licensing (82)
Liver cancer (98)
Longevity (38)
Lung cancer (914)
Lung diease (18)
Lymphoma (455)
Machine learning (56)
Management (40)
Manufacturing (1468)
Marketing (33)
MASH (185)
Medical affairs (5)
Medical device (12381)
Medtech (12617)
Mergers & acquisitions (16796)
Metabolic disorders (1555)
mRNA (226)
Multiple sclerosis (206)
Multispecific (4)
NASH (15)
Netherlands (21)
Neurodegenerative disease (447)
Neuropsychiatric disorders (91)
Neuroscience (3114)
Neurotech (3)
NextGen: Class of 2026 (4371)
Non-profit (2226)
Now hiring (41)
Obesity (674)
Opinion (208)
Ovarian cancer (215)
Pain (253)
Pancreatic cancer (368)
Parkinson's disease (371)
Partnered (29)
Patents (613)
Patient advocacy (4)
Patient recruitment (765)
Patient selection (78)
Peanut (67)
People (45148)
Peptides (29)
Pharmaceutical (29)
Pharmacy benefit managers (23)
Phase 1 (17961)
Phase 2 (26172)
Phase 3 (20614)
Pipeline (12162)
Policy (253)
Postmarket research (1864)
Preclinical (7222)
Press Release (69)
Prostate cancer (333)
Psychedelics (48)
Radioligand (2)
Radiopharmaceuticals (349)
Rare diseases (1157)
Real estate (4433)
Recruiting (34)
Regenerative medicine (25)
Regulatory (22946)
Reports (39)
Research institute (1431)
Resumes & cover letters (104)
Rett syndrome (55)
RNA editing (24)
RSV (73)
Schizophrenia (165)
Series A (266)
Series B (187)
Service/supplier (6)
Sickle cell disease (110)
Special edition (15)
Spinal muscular atrophy (142)
Sponsored (45)
Startups (2564)
State (1)
Stem cells (5)
Stomach cancer (17)
Substance use disorders (12)
Supply chain (155)
Switzerland (8)
Tariffs (89)
Tax incentives (1)
The Weekly (100)
Vaccines (929)
Venture capital (79)
Weight loss (432)
Wet AMD (4)
Women's health (152)
Worklife (12)
Date
Last 7 days (714)
Last 30 days (2427)
Last 365 days (26666)
2026 (22367)
2025 (26263)
2024 (29394)
2023 (33177)
2022 (43251)
2021 (46611)
2020 (44374)
2019 (36331)
2018 (27560)
2017 (27226)
2016 (25620)
2015 (30507)
2014 (22657)
2013 (18636)
2012 (20450)
2011 (21223)
2010 (18937)
Location
Africa (480)
Alabama (93)
Alaska (3)
Arizona (254)
Arkansas (12)
Asia (35087)
Australia (5759)
California (13846)
Canada (3626)
China (1676)
Colorado (569)
Connecticut (609)
Delaware (442)
Europe (77072)
Florida (2076)
Georgia (460)
Hawaii (5)
Idaho (50)
Illinois (1186)
India (131)
Indiana (658)
Iowa (19)
Japan (718)
Kansas (134)
Kentucky (39)
Louisiana (59)
Maine (91)
Maryland (1665)
Massachusetts (9820)
Michigan (412)
Minnesota (699)
Mississippi (6)
Missouri (167)
Montana (23)
Nebraska (15)
Nevada (180)
New Hampshire (83)
New Jersey (3925)
New Mexico (29)
New York (3559)
North Carolina (1693)
North Dakota (10)
Northern California (7114)
Ohio (434)
Oklahoma (22)
Oregon (36)
Pennsylvania (2945)
Puerto Rico (35)
Rhode Island (42)
South America (832)
South Carolina (91)
South Dakota (1)
Southern California (5597)
Tennessee (233)
Texas (2129)
United States (48979)
Utah (349)
Vermont (2)
Virginia (381)
Washington D.C. (59)
Washington State (1107)
West Virginia (4)
Wisconsin (165)
Wyoming (5)
580,745 Results for "janssen pharmaceutica products l p".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Icahn Enterprises L.P. Announces Q2 2026 Earnings Conference Call
July 24, 2026
·
1 min read
Press Releases
Northwest Biotherapeutics and the UK National Health Service Blood and Transplant Announce Collaboration to Support DCVax®-L Production
October 8, 2026
·
5 min read
Press Releases
UCB Establishes the Emmanuel Janssen Endowed Chair for the Evaluation of Medicines at Brigham and Women’s Hospital
October 26, 2026
·
8 min read
Press Releases
AINN-P1: Small Model, Big Intelligence
AINN-P1: Small Model, Big IntelligenceHow does a 167M-parameter protein foundation model outperform a 650M general-purpose model on the tasks that matter?
September 10, 2026
·
1 min read
Press Releases
L7 Informatics Advocates for Neuro-Symbolic AI in Regulated Life Sciences
L7 Informatics’ position is that generative AI has been deployed in regulated science with only half the architecture it needs, and that the missing half is an active knowledge graph generated at the point of execution.
July 23, 2026
·
1 min read
Press Releases
Altruist Biologics Completes First Commercial PPQ Campaign of its 20,000L Production Line at the Hangzhou Site
August 5, 2026
·
3 min read
Press Releases
GCAR and Purdue Pharma L.P. Announce Initiation of Tinostamustine in GBM AGILE Trial
April 8, 2026
·
6 min read
MustGrow and Janssen PMP, a division of Janssen Pharmaceutica NV, Announce Significant Project Expansion
MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the “Company” or “MustGrow”), and Janssen PMP, a division of Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies of Johnson & Johnson (NYSE: JNJ) (“Janssen PMP”) are pleased to announce a significant expansion to their existing Exclusive Evaluation and Option Agreement
September 6, 2023
·
9 min read
Press Releases
Inside the 98 Percent: L7 Informatics on the Operational Harness That Determines Pharma’s Agentic AI Outcomes
L7 Informatics CEO, Vasu Rangadass, Ph.D., examines the architectural principle separating pharmaceutical AI experimentation from enterprise-scale deployment.
June 12, 2026
·
1 min read
MustGrow and Janssen PMP, a Division of Janssen Pharmaceutica NV, Extend Exclusive Global Partnership
MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the “Company”, “MustGrow”), and JANSSEN PMP, a division of Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies of Johnson & Johnson
May 23, 2023
·
7 min read
1 of 58,075
Next
